1-13 of 13
Natasha Rekhtman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3858: Exploring Exportin-1 as a therapeutic vulnerability in squamous cell carcinoma

Vidushi Durani, Rebecca Caeser, Charles M. Rudin, Alvaro Quintanal-Villalonga, Harsha Sridhar, Parvathy Manoj, Sam E. Tischfield, Marina Asher, Umeshkumar Bhanot, Jacklynn V. Egger, Nicholas D. Socci D. Socci, Nisargbhai S S. Shah, Elisa de Stanchina, Natasha Rekhtman
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3858.
https://doi.org/10.1158/1538-7445.AM2023-3858
Published: 04 April 2023
View article titled, Abstract 3858: Exploring Exportin-1 as a therapeutic vulnerability in squamous cell carcinoma
Journal Articles

Abstract 868: Splicing factor mutant lung cancers: A comprehensive molecular and clinicopathologic characterization

Guilherme Harada, Christina J. Falcon, Fernando C. Santini, Jason C. Chang, Soo R. Yang, Maria E. Arcila, Natasha Rekhtman, Alexander Drilon
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 868.
https://doi.org/10.1158/1538-7445.AM2022-868
Published: 15 June 2022
View article titled, Abstract 868: Splicing factor mutant lung cancers: A comprehensive molecular and clinicopathologic characterization
Journal Articles

Abstract 658: AKT pathway as a therapeutic target to constrain lineage plasticity leading to histological transdifferentiation

Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, Yingqian A. Zhan, Fathema Uddin, Viola Allaj, Parvathy Manoj, Nisargbhai S. Shah, Umesh K. Bhanot, Jacklynn Egger, Juan Qiu, Elisa de Stanchina, Natasha Rekhtman, Brian Houck-Loomis, Richard P. Koche, Helena A. Yu, Triparna Sen, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 658.
https://doi.org/10.1158/1538-7445.AM2022-658
Published: 15 June 2022
View article titled, Abstract 658: AKT pathway as a therapeutic target to constrain lineage plasticity leading to histological transdifferentiation
Journal Articles

Abstract CT112: AI-powered and manual assessment of PD-L1 are comparable in predicting response to neoadjuvant atezolizumab in patients (pts) with resectable non-squamous, non-small cell lung cancer (NSCLC)

John Abel, Christopher Rivard, Filip Kos, Guillaume Chhor, Yi Liu, Jennifer Giltnane, Sara Hoffman, Murray Resnick, Cyrus Hedvat, Amaro Taylor-Weiner, Farah Khalil, Alan Nicholas, Gregory A. Fishbein, Lynette M. Sholl, Natasha Rekhtman, Stephanie Hennek, Ilan Wapinski, Ann Johnson, Michael Montalto, Katja Schulze, Bruce E. Johnson, David P. Carbone, Konstantin Shilo, Andrew H. Beck, Sanja Dacic, William D. Travis, Ignacio Wistuba
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT112.
https://doi.org/10.1158/1538-7445.AM2022-CT112
Published: 15 June 2022
View article titled, Abstract CT112: AI-powered and manual assessment of PD-L1 are comparable in predicting response to neoadjuvant atezolizumab in patients (pts) with resectable non-squamous, non-small cell lung cancer (NSCLC)
Journal Articles

Abstract 5239: Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation

Yonina R. Murciano-Goroff, Srinivasaraghavan Kannan, Jason C. Chang, Ryma Benayed, Ilya Blokhin, Natasha Rekhtman, Ann Elizabeth Sisk, Jaime Gibson, Lia Judka, Lauren Kaplanis, Madeline Merrill, Erica Sgroe, Chandra S. Verma, Alexander Drilon, Emiliano Cocco
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5239.
https://doi.org/10.1158/1538-7445.AM2022-5239
Published: 15 June 2022
View article titled, Abstract 5239: Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation
Journal Articles

Abstract 2506: Smarca4 inactivation promotes lineage-specific transformation and early metastatic features in the lung

Carla P. Concepcion, Sai Ma, Lindsay M. LaFave, Arjun Bhutkar, Manyuan Liu, Lydia P. DeAngelo, Jonathan Y. Kim, Isabella Del Priore, Adam J. Schoenfeld, Vinay K. Kartha, Peter M. Westcott, Francisco J. Sánchez-Rivera, Kevin Meli, Manav Gupta, Gregory J. Riely, Natasha Rekhtman, Charles M. Rudin, Carla F. Kim, Aviv Regev, Jason D. Buenrostro, Tyler Jacks
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2506.
https://doi.org/10.1158/1538-7445.AM2021-2506
Published: 01 July 2021
View article titled, Abstract 2506: <em>Smarca4</em> inactivation promotes lineage-specific transformation and early metastatic features in the lung
Journal Articles

Abstract 1511: A highly plastic cell state emerges during lung adenocarcinoma evolution

Jason Earl Chan, Nemanja Despot Marjanovic, Matan Hofree, David Canner, Katherine Wu, Griffin Hartmann, Olivia C. Smith, Jonathan Kim, Anna Hudson, Ayshwarya Subramanian, Kenneth Pitter, Natasha Rekhtman, Pierre P. Massion, John T. Poirier, Charles M. Rudin, Tyler Jacks, Aviv Regev, Tuomas Tammela
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1511.
https://doi.org/10.1158/1538-7445.AM2020-1511
Published: 15 August 2020
View article titled, Abstract 1511: A highly plastic cell state emerges during lung adenocarcinoma evolution
Journal Articles

Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids

Saurabh V. Laddha, Edaise M. da Silva, Kenneth Robzyk, Brian R. Untch, Hua Ke, Natasha Rekhtman, John T. Poirier, William D. Travis, Laura H. Tang, Chang S. Chan
Journal: Cancer Research
Cancer Res (2019) 79 (17): 4339–4347.
https://doi.org/10.1158/0008-5472.CAN-19-0214
Published: 03 September 2019
View article titled, Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids
Open the PDF for Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids in another window
Includes: Supplementary data
Journal Articles

Abstract LB-154: Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small cell lung carcinoma (NSCLC): A proposal for quantitative immune-related pathologic response criteria (irPRC)

Tricia R. Cottrell, Julie E. Stein, Jamie E. Chaft, Elizabeth D. Thompson, Natasha Rekhtman, Valsamo Anagnostou, Kellie N. Smith, Amy S. Duffield, Robert A. Anders, James M. Isbell, David R. Jones, Jonathan D. Cuda, Richard Battafarano, Stephen C. Yang, Peter B. Illei, Edward Gabrielson, Frederic Askin, Moises Velez, Matthew D. Hellmann, Jennifer L. Sauter, Ludmila Danilova, Victor E. Velculescu, Jedd D. Wolchok, Suzanne L. Topalian, Julie R. Brahmer, Drew M. Pardoll, Ashley Cimino-Mathews, Patrick M. Forde, Janis M. Taube
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): LB-154.
https://doi.org/10.1158/1538-7445.AM2018-LB-154
Published: 01 July 2018
View article titled, Abstract LB-154: Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small cell lung carcinoma (NSCLC): A proposal for quantitative immune-related pathologic response criteria (irPRC)
Journal Articles

Abstract CT079: Neoadjuvant PD-1 blockade in resectable lung cancer

Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith, Valsamo Anagnostou, Tricia R. Cottrell, Matthew D. Hellmann, Marianna Zahurak, Stephen C. Yang, David R. Jones, Stephen Broderick, Richard J. Battafarano, Moises J. Velez, Natasha Rekhtman, Zachary Olah, Jarushka Naidoo, Kristen A. Marrone, Franco Verde, Haidan Guo, Jiajia Zhang, Justina X. Caushi, Hok Yee Chan, John-William Sidhom, Robert B. Scharpf, James White, Edward Gabrielson, Hao Wang, Gary L. Rosner, Valerie Rusch, Jedd D. Wolchok, Taha Merghoub, Janis M. Taube, Victor E. Velculescu, Suzanne L. Topalian, Julie R. Brahmer, Drew M. Pardoll
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT079.
https://doi.org/10.1158/1538-7445.AM2018-CT079
Published: 01 July 2018
View article titled, Abstract CT079: Neoadjuvant PD-1 blockade in resectable lung cancer
Journal Articles

Abstract 610: Prospective genomic characterization of small cell lung cancer by targeted next generation sequencing

Helen H. Won, M. Catherine Pietanza, Lee M. Krug, Anna M. Varghese, Natasha Rekhtman, Lu Wang, William Travis, Paul K. Paik, Gregory J. Riely, Maureen F. Zakowski, Marc Ladanyi, Mark G. Kris, Charles M. Rudin, Michael F. Berger
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 610.
https://doi.org/10.1158/1538-7445.AM2015-610
Published: 01 August 2015
View article titled, Abstract 610: Prospective genomic characterization of small cell lung cancer by targeted next generation sequencing
Journal Articles

Abstract 1202: Expression signature for classification of non-small cell lung cancer.

Luc Girard, Ignacio Wistuba, William D. Travis, Natasha Rekhtman, Milind Suraokar, Carmen Behrens, John D. Minna, Adi F. Gazdar
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1202.
https://doi.org/10.1158/1538-7445.AM2013-1202
Published: 15 April 2013
View article titled, Abstract 1202: Expression signature for classification of non-small cell lung cancer.
Journal Articles

Reversal of Tumorigenicity and the Block to Differentiation in Erythroleukemia Cells by GATA-1

Kevin S. Choe, Farshid Radparvar, Igor Matushansky, Natasha Rekhtman, Xing Han, Arthur I. Skoultchi
Journal: Cancer Research
Cancer Res (2003) 63 (19): 6363–6369.
Published: 14 October 2003
View article titled, Reversal of Tumorigenicity and the Block to Differentiation in Erythroleukemia Cells by GATA-1
Open the PDF for Reversal of Tumorigenicity and the Block to Differentiation in Erythroleukemia Cells by GATA-1 in another window